Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Kureha's new agent for renal disorders

May 3, 1996

Fujisawa synthesizes novel beta3-agonist

May 3, 1996

Enadoline claimed for treatment of BPH

April 26, 1996

5alpha-Reductase inhibitors for BPH disclosed by Lilly

April 26, 1996

SR-48692 claimed for use as diuretic

April 26, 1996

FDA gives green light to Milkhaus for HP-4 clinical trial

April 19, 1996

SNAP-5399 presented at 211th ACS

April 19, 1996

FDA approves lasers for treating BPH

April 5, 1996

Synsorb develops drug for hemorrhagic colitis

March 15, 1996

VML-252 for hyperphosphatemia

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...